Llwytho...
Equity in HTA: what doesn’t get measured, gets marginalised
When making recommendations about the public funding of new health technologies, policy makers typically pay close attention to quantitative evidence about the comparative effectiveness, cost effectiveness and budget impact of those technologies – what we might call “efficiency” criteria. Less atten...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Isr J Health Policy Res |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502411/ https://ncbi.nlm.nih.gov/pubmed/28694961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13584-017-0162-3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|